ReviewJournal of hepatocellular carcinoma2017

Optimal therapy for patients with hepatocellular carcinoma and resistance or intolerance to sorafenib: challenges and solutions.

Emily M Ray et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.